What is Hormona?
Launched in 2020 by Karolina Löfqvist and Jasmine Tagesson, Hormona is at the forefront of women's health technology. The company develops sophisticated digital tools and hardware designed to empower individuals to monitor, understand, and effectively manage hormonal fluctuations. By leveraging data-driven insights and innovative hardware, Hormona aims to provide personalized health solutions, addressing a critical gap in proactive women's healthcare and establishing itself as a key player in the rapidly evolving digital health landscape.
How much funding has Hormona raised?
Hormona has raised a total of $6.8M across 2 funding rounds:
Seed
$6.7M
Grant
$136K
Seed (2025): $6.7M with participation from Voima Ventures, Techstars, DLF Venture, Supernode Global, and Nascent Investments
Grant (2025): $136K led by UK Research & Innovation
Key Investors in Hormona
Voima Ventures
Voima Ventures is a venture capital firm specializing in deep tech ventures in the Nordics and Baltics, focusing on science-driven innovation to address global challenges. They support founders in scaling solutions from pre-seed to series B stages.
Techstars
Techstars is a global investment accelerator that supports entrepreneurs by connecting startups, investors, and corporations to foster thriving startup communities and enable individuals to contribute to entrepreneurial success.
DLF Venture
DLF Venture is a family-owned investment company providing funding and support to consumer-oriented teams and brands, with a focus on building strong brands and offering continuous support through business milestones.
What's next for Hormona?
The recent major strategic investment positions Hormona for accelerated expansion and product development. With a foundation built on addressing complex hormonal health challenges through technology, the company is poised to enhance its offerings and broaden its market reach. Future endeavors will likely focus on scaling operations, further refining its digital platforms and hardware, and potentially exploring new therapeutic areas within women's health. The backing from prominent investors suggests a strong belief in Hormona's potential to disrupt the healthtech sector and deliver significant value to its users.
See full Hormona company page
